Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-1864-2017

Software version 4.44A utilized on the BD MAX System

Publicado el 26 de abril de 2017 · Inicio del retiro: 29 de julio de 2015

Resumen

FDA registra el retiro Z-1864-2017 de dispositivos médicos de Clase II, publicado el 26 de abril de 2017 e iniciado el 29 de julio de 2015. Empresa responsable: BD LIFE SCIENCES; Estado: Finalizado; Cantidad reportada: There are 29 US customers and 5 ex-US regions with a BD MAX System running software version 4.44A.; Lote: Catalog number 441916. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers utilizing only IVD assays are not affected. This anomaly may cause the OSR customer system to incorrectly switch the columns of the truth table on the users display. If the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting. BD is able to trace the issue to a limited number of instruments that have software version 4.44A installed. Note that the problem only affects customers that are either creating a new UDP with Result Logic or modifying the Result Logic of an existing UDP.

Qué hacer

Voluntary: Firm initiated · E-Mail

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
BD LIFE SCIENCES
Distribuidor
Worldwide Distribution - US Distribution to the states of : CA, CO, FL, IL, MN, MO, MT, NE, NJ, NY, OH, OR, PA, TX, TN, WA, WI., and to the countries of : Canada, Hong Kong, Taiwan, Turkey and Europe. Federal Government Agency sales/distribution centers or foreign countries VA Fort Harrison and VAMC Austin.
Lote
Catalog number 441916
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Software version 4.44A utilized on the BD MAX System fue retirado del mercado?

Sí. FDA publicó el retiro Z-1864-2017 el 26 de abril de 2017. Peligro reportado: The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers utilizing only IVD assays are not affected. This anomaly may cause the OSR customer system to incorrectly switch the columns of the truth table on the users display. If the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting. BD is able to trace the issue to a limited number of instruments that have software version 4.44A installed. Note that the problem only affects customers that are either creating a new UDP with Result Logic or modifying the Result Logic of an existing UDP.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · E-Mail